Anogenital malignancies and pre-malignancies

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 8, 2011, Pages 885-895

  Henquet, C J M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; PODOPHYLLOTOXIN; RETINOIC ACID; WART VIRUS VACCINE;

ANUS CARCINOMA; BOWEN DISEASE; BOWENOID PAPULOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONDYLOMA ACUMINATUM; CRYOTHERAPY; ELECTROCOAGULATION; ERYTHROPLASIA OF QUEYRAT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LICHEN SCLEROSUS ET ATROPHICUS; LOW LEVEL LASER THERAPY; MELANOMA; PAGET SKIN DISEASE; PENIS CARCINOMA; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; PUVA; REVIEW; RISK FACTOR; SKIN CANCER; VACCINATION; VERRUCA VULGARIS; VULVA CARCINOMA; WART VIRUS;

ANUS NEOPLASMS; CARCINOMA; HIV INFECTIONS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRECANCEROUS CONDITIONS; UROGENITAL NEOPLASMS;

EID: 79960269496     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03969.x     Document Type: Review

References (134)

1. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-226. (Pubitemid 36152435)
2. Ho GY, Bierman R, Beardsly L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428. (Pubitemid 28135669)
3. Molano M, Van den BA, Plummer M, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population based 5-year follow-up study. Am J Epidemiol 2003; 158: 486-494. (Pubitemid 37022847)
4. Wheeler CM, Hunt WC, Schiffman M, et al. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006; 194: 1291-1299. (Pubitemid 44630975)
5. Weinstock H, Berman S, Cates W Jr,. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36: 6-10. (Pubitemid 38258322)
6. Myers ER, Mc Crory DC, Nanda K, et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151: 1158-1171. (Pubitemid 30451948)
7. Revzina NV, Diclemente RJ,. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int J STD AIDS 2005; 16: 528-537. (Pubitemid 41192302)
8. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183: 1554-1564. (Pubitemid 32466692)
9. Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186: 1396-1402. (Pubitemid 35286106)
10. Baldwin SB, Wallace DR, Papenfuss MR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187: 1064-1070. (Pubitemid 36399348)
11. Hernandez BY, Mc Duffie K, Goodman MT, et al. Comparison of physician-and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 2006; 44: 513-517. (Pubitemid 43222245)
12. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189: 677-685. (Pubitemid 38270922)
13. Partridge JM, Koutsky LA,. Genital human papillomavirus infection in men. Lancet Infect Dis 2006; 6: 21-31. (Pubitemid 41831374)
14. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194: 1044-1057. (Pubitemid 44547644)
15. US Cancer Statistics Working Group. United States Cancer Statistics: 2003. Incidence and Mortality. US Department of Health and Human Services, CDC and the National Cancer Institute, Atlanta, GA, 2005.
16. Hampl M, Sarajuuri H, Wentzensen N, et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 2006; 108: 1361-1368. (Pubitemid 44901008)
17. Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006; 107: 1018-1022.
18. Schiffman M, Kjaer SK,. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 14-19.
19. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101: 281-288. (Pubitemid 38890830)
20. Schottenfeld D, Winawer S,. Cancers of the large intestine. In, Scottenfeld D, Fraumeni J, eds. Cancer Epidemiology and Prevention. Oxford University Press, New York, NY, 1996: 813-840.
21. Hillemanns P, Breugelmans JG, Gieseking F, et al. Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study. BMC Infect Dis 2008; 8: 76.
22. Scholefield JH, Hickson WG, Smith JH, et al. Anal intraepithelial neoplasia part of a multifocal disease process. Lancet 1992; 340: 1271-1273.
23. HadziÄ B, DjurdjeviÄ S, HadziÄ M,. Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region. Med Pregl 1998; 51: 265-270.
24. Majewski S, Jablonska S,. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36: 659-685. (Pubitemid 27215352)
25. Zur Hausen H,. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009; 384: 260-265.
26. Mikhail GR,. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol 1980; 6: 1027-1035.
27. Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (Suppl3): S3/1-S3/10.
28. Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26 (Suppl 10): K17-K28.
29. Dunne EF, Datta SD, E Markowitz L,. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US. Cancer 2008; 113 (10 Suppl): 2995-3003.
30. Powell JJ, Wojnarowska F,. Lichen sclerosus. Lancet 1999; 353: 1777-1783. (Pubitemid 29240387)
31. Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50: 477-480. (Pubitemid 41022264)
32. Micali G, Innocenzi D, Nasca MR, et al. Squamous cell carcinoma of the penis. J Am Acad Dermatol 1996; 35: 432-451. (Pubitemid 26299236)
33. Buechner SA,. Common skin disorders of the penis. BJU International 2002; 90: 498-506. (Pubitemid 34989236)
34. Pugliese JM, Morey AF, Peterson AC,. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007; 178: 2268-2276. (Pubitemid 350052170)
35. Hart WR, Norris HJ, Helwig EB,. Relation of lichen sclerosis et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975; 45: 369-377.
36. Chiesa-Vottero A, Dvoretsky PM, Hart WR,. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006; 30: 310-318. (Pubitemid 43740162)
37. Poulsen H, Junge J, Vyberg M, et al. Small vulvar squamous cell carcinomas and adjacent tissues. A morphologic study. APMIS 2003; 111: 835-842. (Pubitemid 37222727)
38. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97: 1135-1139.
39. Rubio JFP, Pevenga AF, Alfosa J,. Squamous cell carcinoma of the penis arising on lichen sclerosus et atrophicus. J Eur Acad Derm Venereol 1999; 12: 153-156. (Pubitemid 29234450)
40. Perceau G, Derancourt C, Clavel C, et al. Clinical and laboratory investigations. Lichen sclerosus is frequently present in penile squamous cell carcinoma but is not always associated with oncogenic human papillomavirus. Br J Dermatol 2003; 148: 934-938. (Pubitemid 36750785)
41. Powell J, Robson A, Cranston D, Wojnarowska F, Turner R,. High incidence of lichen sclerosus in patients with carcinoma of the penis. Br J Dermatol 2001; 145: 85-89. (Pubitemid 32862791)
42. Kopf AW, Bart RS,. Multiple Bowenoid papules of the penis: a new entity? J Dermatol Surg Oncol 1977; 3: 265-269. (Pubitemid 8127489)
43. Lloyd KM,. Multicentric pigmented Bowen's disease of the groin. Arch Dermatol 1970; 101: 48-51.
44. Kimura S, Hirai A, Harara R, et al. Bowen's disease. Report of a case and a possible etiologic role of human papillomavirus. Dermatologica 1978; 157: 229-237. (Pubitemid 8387356)
45. Wade TR, Kopf AW, Ackerman AB,. Bowenoid papulosis of the penis. Cancer 1978; 42: 1890-1903. (Pubitemid 9053531)
46. Bergeron C, Naghashfar Z, Canaan C, et al. Human papillomavirus type 16 in intraepithelial neoplasia (Bowenoid papulosis) and coexistent invasive carcinoma of the vulva. Int J Gynecol Pathol 1987; 6: 1-11. (Pubitemid 17031205)
47. Della Torre G, Donghi R, Longoni A, et al. HPV DNA in intraepithelial neoplasia and carcinoma of vulva and penis. Diagn Mol Pathol 1992; 1: 25-30.
48. Kato T, Saijyo S, Hatchome N, et al. Detection of human papillomavirus type 16 in Bowenoid papulosis and invasive carcinoma occurring in the same patient with a history of cervical carcinoma. Arch Dermatol 1988; 124: 851-852.
49. Park KC, Kim KH, Youn SW, et al. Heterogeneity of human papillomavirus DNA in a patient with Bowenoid papulosis that progressed to squamous cell carcinoma. Br J Dermatol 1998; 139: 1087-1091.
50. Rogozinski TT, Janniger CK,. Bowenoid papulosis. Am Fam Physician 1988; 38: 161-164.
51. Ahmed AM, Madkan V, Tyring SK,. Human papillomaviruses and genital disease. Dermatol Clin 2006; 24: 157-165.
52. Gimeno E, Vilata JJ, Sanchez JL,. Bowenoid papulosis: clinical and histological study of eight cases. Genitourin Med 1987; 63: 109-113. (Pubitemid 17047271)
53. Steffen C,. Concurrence of condylomata acuminata and Bowenoid papulosis: confirmation of the hypothesis that they are related conditions. Am J Dermatopathol 1982; 4: 5-8. (Pubitemid 12130743)
54. Knoll LD, Sequra JW, Benson RC, et al. Bowenoid papulosis of the penis: successful management with neodymium: YAG laser. J Urol 1988; 139: 1307-1309.
55. Mahto M, Nathan M, O'Mahony C,. More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia. Int J STD AIDS 2010; 21: 8-16.
56. Van Seters M, van Beurden M, ten Kate FJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Eng J Med 2008; 358: 1465-1473. (Pubitemid 351482738)
57. Mathiessen O, Buus SK, Cramers M,. Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomised, double-blinded study. Gynecol Oncol 2007; 107: 219-222. (Pubitemid 47575715)
58. Le T, Menard C, Hicks-Boucher W, et al. Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasisa. Gynecol Oncol 2007; 106: 579-584. (Pubitemid 47302478)
59. Lavazzo C, Pitsouni E, Athanasiou S, et al. Imiquimod for the treatment of vulvar and vaginal intraepithelial neoplasia. Int J Gynecol Obstet 2008; 101: 3-10.
60. Gerber GS,. Carcinoma in situ of the penis. J Urol 1994; 151: 829-833. (Pubitemid 24083437)
61. Fehr MK, Hornung R, Schwarz VA, et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulenic acid. Gynecol Oncol 2001; 80: 62-66. (Pubitemid 32062090)
62. King CM, Yates VM, Dave VK,. Multicentric pigmented Bowen's disease of the genitalia associated with carcinoma in situ of the cervix. Br J Vener Dis 1984; 60: 406-408. (Pubitemid 15198267)
63. Belilovski de C, Lessana-Leibowitch M,. Bowen's disease and Bowenoid papulosis: comparative clinical, viral, and disease progression aspects. Contacept Fertil Sex 1993; 21: 231-236. (Pubitemid 23158272)
64. Beck DE, Fazio VW, Jagelman DG,. Perianal Bowen's disease. Dis Colon Rectum 1988; 31: 419-422.
65. Cleary RK, Schaldenbrand JD, Fowler JJ, et al. Perianal Bowen's disease and anal intraepithelial neoplasia: a review of the literature. Dis Colon Rectum 1999; 42: 945-951. (Pubitemid 29328468)
66. Sarmiento JM, Wolff BG, Burgart LJ, et al. Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies. Dis Colon Rectum 1997; 40: 912-918. (Pubitemid 27355393)
67. Wieland U, Jurk S, Weissenborn S, et al. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000; 115: 396-401.
68. Micali G, Nasca MR, De Pasquale R,. Erythroplasia of Queyrat treated with imiquimod 5% cream. J Am Acad Dermatol 2006; 55: 901-903. (Pubitemid 44556850)
69. Kanitakis J,. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 2007; 21: 581-590. (Pubitemid 46916755)
70. Park S, Grossfeld GD, Mcaninch JW, et al. Extramammary Paget's disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy. J Urol 2001; 166: 2112-2117.
71. Lai YL, Yang WG, Tsay PK, et al. Penoscrotal extramammary Paget's disease: a review of 33 cases in a 20-year experience. Plast Reconstr Surg 2003; 112: 1017-1023.
72. Balducci L, Crawford ED, Smith GF, et al. Extramammary Paget's disease: an annotated review. Cancer Invest 1988; 6: 293-303.
73. Chanda JJ,. Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 1995; 13: 1009-1014.
74. Molinie V, Paniel BJ, Lessana-Leibowitch M, et al. Paget disease of the vulva. 36 cases. Ann Dermatol Venereol 1993; 120: 522-527.
75. Sleater JP, Ford MJ, Beers BB,. Extramammary Paget's disease associated with prostate adenocarcinoma. Hum Pathol 1994; 25: 615-617. (Pubitemid 24198115)
76. Yoon SN, Park IJ, Kim HC, et al. Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms. Int J Colorectal Dis 2008; 23: 1125-1130.
77. Kitajima S, Yamamoto K, Tsuji T, et al. Triple extramammary Paget's disease. Dermatol Surg 1997; 23: 1035-1038. (Pubitemid 27512063)
78. Sasaki M, Terada T, Nakanuma Y, et al. Anorectal mucinous adenocarcinoma associated with latent perianal Paget's disease. Am J Gastroenterol 1990; 85: 199-202. (Pubitemid 20067087)
79. Cohen PR, Schulze KE, Tschen JA, et al. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 2006; 99: 396-402.
80. Moreno-Arias GA, Conill C, Soal-Casas MA, et al. Radiotherapy for in situ extramammary Paget disease of the vulva. J Dermatol Treat 2003; 14: 119-123. (Pubitemid 36648703)
81. Hatch KD, Davis JR,. Complete resolution of Paget disease of the vulva with imiquimod cream. J Low Genit Tract Dis 2008; 12: 90-94. (Pubitemid 351457913)
82. Mirer E, El Sayed F, Ammoury A, et al. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. J Dermatol Treat 2006; 17: 167-171. (Pubitemid 44147836)
83. Zampogna JC, Flowers FP, Roth WI, et al. Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol 2002; 47: S299-235.
84. Ye JN, Rhew DC, Yip F, et al. Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report. Cutis 2006; 77: 245-250. (Pubitemid 43723544)
85. Hatta N, Morita R, Yamada M, et al. Sentinal node biopsy in patients with extramammary Paget's disease. Dermatol Surg 2004; 30: 1329-1334. (Pubitemid 39422961)
86. Ariel IM,. Malignant melanoma of the female genital system: a report of 48 patients and review of the literature. J Surg Oncol 1981; 16: 371-383. (Pubitemid 11156442)
87. Patrick RJ, Fenske NA, Messina JL,. Primary mucosal melanoma. J Am Acad Dermatol 2007; 56: 828-834. (Pubitemid 46560994)
88. DeMatos P, Tyler D, Seigler HF,. Mucosal melanoma of the female genitalia: a clinicopathologic study of 43 cases at Duke Medical Center. Surgery 1998; 124: 38-48. (Pubitemid 28354684)
89. Suwandinata FS, Bohle RM, Omwandho CA, et al. Management of vulvar melanoma and review of the literature. Eur J Gynaecol Oncol 2007; 28: 220-224. (Pubitemid 46985647)
90. Zur Hausen H,. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13.
91. Gibson GE, Ahmed I,. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases. J Am Acad Dermatol 2001; 45: 68-71. (Pubitemid 32655695)
92. Nahass GT, Blauvelt A, Leonardi CL, et al. Basal cell carcinoma of the scrotum. Report of three cases and review of the literature. J Am Acad Dermatol 1992; 26: 574-578.
93. Nehal KS, Levine VJ, Ashinoff R,. Basal cell carcinoma of the genitalia. Dermatol Surg 1998; 24: 1361-1363. (Pubitemid 29018229)
94. Gleeson NC, Ruffolo EH, Hoffman MS, et al. Basal cell carcinoma of the vulva with groin node metastasis. Gynecol Oncol 1994; 53: 366-368. (Pubitemid 24187868)
95. Karagas MR, Nelson HH, Zens MS, et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007; 18: 776-784. (Pubitemid 350295177)
96. Senkus E, Konefka T, Nowaczyk M, et al. Second lower genital tract squamous cell carcinoma following cervical cancer. A clinical study of 46 patients. Acta Obstet Gynecol Scand 2000; 79: 765-770.
97. Ansink AC, Krul MRL, Weger de RA,. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol Oncol 1994; 52: 180-184. (Pubitemid 24064367)
98. Jones RW, Baranyai J, Stables S,. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997; 90: 448-452. (Pubitemid 27357940)
99. Neill SM, Lessana-Leibowitch M, Pelisse M, et al. Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am J Obstet Gynecol 1990; 162: 1633-1634. (Pubitemid 20222081)
100. Andersen WA, Franquemont DW, Williams J, et al. Vulvar squamous cell carcinoma and papillomaviruses: two separate entities? Am J Obstet Gynecol 1991; 165: 329-336.
101. Husseinzadeh N, DeEulis T, Newman N, et al. HPV changes and their significance in patients with invasive squamous cell carcinoma of the vulva: A clinicopathologic study. Gynecol Oncol 1991; 43: 237-241.
102. Sturgeon SR, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer incidence trends (1973-1987). Am J Obstet Gynecol 1992; 166: 1482-1485.
103. Nieuwenhof van de HP, Avoort van der IA, Hullu de JA,. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008; 68: 131-156.
104. Joura EA, Lösch A, Haider-Angeler MG, et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000; 45: 613-615. (Pubitemid 30661117)
105. Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women: a clinicopathological study of 21 cases. Gynecol Oncol 2002; 84: 94-101. (Pubitemid 34056473)
106. Messing MJ, Gallup DG,. Carcinoma of the vulva in young women. Obstet Gynecol 1995; 86: 51-54.
107. Van Seters M, van Beurden M, de Craen AJ,. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 645-651. (Pubitemid 40614916)
108. Jones RW, Rowan DM, Stewart AW,. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005; 106: 1319-1326. (Pubitemid 41668952)
109. Chafe W, Richards A, Morgan L, et al. Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN). Gynecol Oncol 1988; 31: 154-165.
110. Hacker NF, Van der Velden J,. Conservative management of early vulvar cancer. Cancer 1993; 71: 1673-1677. (Pubitemid 23056090)
111. Thomas GM, Dembo AJ, Bryson SC, et al. Changing concepts in the management of vulvar cancer. Gynecol Oncol 1991; 42: 9-21.
112. Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68: 733-740. (Pubitemid 17190208)
113. Stern RS, Members of the Photochemotherapy Follow-up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990; 322: 1093-1097. (Pubitemid 20149525)
114. McGarry GW,. Genital tumors among men with psoriasis exposed to PUVA. N Engl J Med 1990; 323: 684. (Pubitemid 20280213)
115. Palewsky J,. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep 2008; 5: 78-85.
116. Palefski JM,. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and woman. J Natl Cancer Inst Monogr 1998; 23: 15-20.
117. Fox PA,. Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 2006; 19: 62-66. (Pubitemid 43032442)
118. Watson AJ, Smith BB, Whitehead MR, et al. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006; 76: 715-717. (Pubitemid 44154742)
119. Place RJ, Gregorcyk SG, Huber PJ, et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001; 44: 506-512. (Pubitemid 32336424)
120. Maclean GM, Coleman DJ,. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89: 709-712. (Pubitemid 47577786)
121. Kuhn L, Sun XW, Wright TC Jr,. Human immunodeficiency virus infection and female lower tract malignancy. Curr Opin Obstet Gynecol 1999; 11: 35-39. (Pubitemid 29081085)
122. Spitzer M,. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv 1999; 54: 131-137. (Pubitemid 29062038)
123. Sanjosé de S, Palefski J,. Cervical and anal HPV infections in HIV positive women and men. Virus Res 2002; 89: 201-211.
124. Bradshaw BR, Nuovo GJ, DiCostanzo D, et al. Human papillomavirus type 16 in a homosexual man. Arch Dermatol 1992; 128: 949-952.
125. Stratton P, Ciacco KH,. Cervical neoplasia in the patient with HIV infection. Curr Opin Obstet Gynecol 1994; 6: 86-91. (Pubitemid 24052452)
126. Paavonen J, Lehtinen M,. Introducing human papillomavirus vaccines-questions remain. Ann Med 2008; 40: 162-166. (Pubitemid 351482542)
127. Rogers LJ, Eva LJ, Luesley DM,. Vaccines against cervical cancer. Curr Opin Oncol 2008; 20: 570-574.
128. D'Hauwers KW, Tjalma WA,. HPV in men. Euro J Gynaecol Oncol 2008; 29: 338-340.
129. Gross G,. Impact of prophylactic human papillomavirus vaccines on dermatology and venereology. G Ital Dermatol Venereol 2008; 143: 259-265.
130. Ma B, Xu Y, Hung C, et al. HPV and therapeutic vaccines: where are we in 2010? Curr Cancer Ther Rev 2010; 6: 81-103.
131. Dasbach E, Insinga R, Elbasha E,. The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK. BJOG 2008; 115: 947-956. (Pubitemid 351841762)
132. De Kok I, van Ballegooijen M, Dik J, et al. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst 2009; 101: 1083-1092.
133. Postma MJ,. Cost-effectiveness analysis of human papillomavirus (HPV) Vaccination in the Netherlands: Recent publication reinforces cost-effectiveness despite misleading conclusion. Vaccine 2010; 28: 873-874.
134. Kim JJ, Goldie SJ,. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008; 359: 821-832.